Walk into almost any large insurance company today, and you’ll hear about innovation.
- Innovation labs.
- Startup accelerators.
- Venture arms.
- Pilot programs.
On paper, it looks impressive in demo days, slick decks, and endless press releases. Behind closed doors, executives quietly ask, “Is this moving the business forward?”
Or are innovation labs devolving into the executive-level “innovation theater” that carriers have committed to avoiding?
Why Carriers Built Innovation Labs in the First Place
Innovation labs didn’t appear out of thin air, but are a response to very real pressure.
- Insurtechs started unbundling parts of the value chain.
- Customer expectations outpaced core systems.
- Legacy platforms made experimentation slow and expensive.
Labs and accelerators promised a solution with a dedicated environment where teams could pilot initiatives, rapidly test new concepts, and engage with startups without risking critical systems. In theory, it was exactly what the industry needed.
Where Things Start to Break Down
The hurdle is rarely in the vision. Challenges emerge in execution.
Many labs struggle with the same issues:
Distance from the Core Business
Labs often operate apart from underwriting, claims, distribution, and IT. This distance eases experimentation but complicates integration, as ideas validated in isolation often stall when faced with real-world constraints.
Pilots Without a Path to Scale
Carriers run many pilots, but few reach production because no one owns the transition from test to operational reality.
Innovation Measured in Activity, Not Impact
Demo days, startup partnerships, and proofs of concept are easy to count. Revenue impact, expense reduction, retention lift, and risk improvement are harder, but those are the metrics that matter.
Cultural Immunity
Even the most promising pilots may face internal resistance. Established teams may raise concerns about compliance, risk, data stewardship, or job security, causing a loss of project momentum.
Accelerators – Fast Starts, Slow Finishes
Startup accelerators bring a different challenge. Accelerators are great at:
- Exposing carriers to new thinking
- Surfacing emerging technology
- Creating optionality.
They’re less effective at:
- Solving carrier-specific problems
- Navigating regulatory complexity
- Integrating with 20-year-old core systems.
Many startups graduate from accelerators with refined commercial propositions, but still lack an empowered internal sponsor to advance actual deployments within the carrier.
What ‘Real Change’ Actually Looks Like
When innovation labs work, a few patterns consistently emerge. Success comes from tackling specific business pain.
For example, don’t just ‘explore AI,’ but act on specific issues like ‘reduce claim cycle time by 15%’ or ‘lower small-group acquisition costs.’
Innovation labs have executive ownership beyond the lab
A business unit leader is accountable for scaling outcomes, not just observing demos.
They plan for integration from day one
Core systems, compliance, data governance, and security aren’t afterthoughts, but design constraints. They kill ideas quickly and make learning visible.
Pruning unpromising projects helps ensure only ideas with real potential advance. Successful labs shut down more projects than they launch.
Failure is expected, documented, and shared. They reward adoption, not just invention.
Impact is measured by real-world use, not by creating clever prototypes. The win isn’t a clever prototype.
It’s something that survives contact with underwriting rules, claims workflows, and customer reality.
Rethinking the Role of Innovation Inside Carriers
The most effective carriers are quietly shifting their thinking about innovation. Lasting value comes from integrating innovation, not just showcasing it.
- From labs as destinations to labs as connectors
- From experimentation theater to execution pipelines
- From startup tourism to problem-driven partnerships.
Some carriers are eliminating standalone labs and embedding innovation capabilities directly within operational teams, where stakeholder incentives are intrinsically aligned with organizational performance.
The Question Worth Asking in 2026
Innovation labs and accelerators aren’t inherently good or bad. They’re tools.
The real question for insurance companies moving forward is, “Can we consistently turn new ideas into measurable business outcomes?” Because in a market where margins are tight, expectations are rising, and technology cycles are accelerating, innovation that doesn’t scale isn’t innovation at all, but overhead.
And the carriers who figure out that difference will quietly pull ahead while everyone else is still hosting demo days. Welcome to the future of insurance that runs at the speed of now.
Agility Holdings Group (AHG) invests in innovative InsurTech, HealthTech, and related companies that aim to revolutionize access to insurance products, establish patient care, and improve health outcomes. Please visit our LinkedIn page for more information about AHG.